We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Publication on Correlation-Associated Peptide Networks of Human Body Fluids

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

BioVisioN AG has announced the publication of an article on Correlation-Associated Peptide Networks (CAN) by Jens Lamerz, member of the BioVisioN bioinformatics team in collaboration with the ETH Zurich and the Swiss Institute of Allergy and Asthma Research (SIAF) in a recent issue of Proteomics (Proteomics 2005, 5, 2789-2798).

Each sample of a complex body fluid contains a snapshot of the respective peptidome. Profiling peptides and small proteins from either human body fluids or tissues by chromatography and subsequent mass spectrometry reveals several thousand individual peptide signals per sample.

A potential diagnostic or bioactive peptide may not only display altered concentration levels in a given disease but should also be connected to other elements of the biological systems. The authors describe and introduce a bioinformatics concept of Correlation-Associated Peptide Networks (CAN) developed by BioVisioNs' researchers.

CAN supports the comprehensive statistical analysis of peptide profiling data and allows associating peptides, which are closely related in terms of peptide biochemistry. Peptides with statistical similarity of their concentrations are grouped in form of networks, and these networks are interpreted in terms of peptide chemistry and biology.

Hans-Dieter Zucht, PhD, Chief Information and Chief Technology Officer of BioVisioN AG, commented, "The potential of this research is profound: These correlation-associated networks will become an important tool for a comprehensive analysis of peptidomes and proteomes and will facilitate discovery of bioactive, therapeutic and diagnostic peptides".